OTCMKTS:BSEM Q2 EPS Estimate Lowered by Zacks Small Cap
BioStem Technologies, Inc. (OTCMKTS:BSEM – Free Report) – Equities research analysts at Zacks Small Cap cut their Q2 2025 EPS estimates for BioStem Technologies in a report released on Tuesday, May 13th. Zacks Small Cap analyst B. Sorensen now anticipates that the company will earn $0.22 per share for the quarter, down from their prior […]
